Q2 2025 Earnings Call Transcript February 12, 2025 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.26, ...
The overhang of debt is one of the greatest obstacles to building genuine wealth.  This is a sentiment espoused vociferously ...